Sanofi stock slips 1.58% from latest report as outlook stays in focus
Published on 11/05/2026 at 18:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSanofi outlook and investor focus
- Sanofi upgraded its full-year 2026 outlook after double-digit third-quarter growth.
- The next listed investor event is the Wolfe Research Healthcare Conference on November 10 in New York.
Sanofi stock traded at 83.69 euros on Lang & Schwarz at 18:16 CET on Thursday, November 5, 2026. That was 1.58 percent below the 85.03-euro quote recorded in the latest report at 16:39 CET on the same day.
See the real-time quote of Sanofi stock for the latest listing.
Higher guidance sets the next test
Sanofi's investor-relations page says management reviewed the third-quarter 2026 results with the financial community on October 30. The company also reported double-digit third-quarter growth and upgraded its full-year 2026 guidance.
For investors, the revised targets shift attention from the initial earnings announcement to delivery through the rest of the year. The next scheduled investor appearance is the Wolfe Research Healthcare Conference in New York on November 10, according to Sanofi's investor-relations calendar.
Sanofi company overview
- Company: Sanofi S.A.
- ISIN: FR0000120578
- Lang & Schwarz quote: 83.69 euros at 18:16 CET on November 5, 2026
- Change since latest report: 1.58 percent lower than the 85.03-euro quote at 16:39 CET
The French market backdrop is tracked through the CAC 40 market overview.
More news and analyses on Sanofi stock are available in the Sanofi stock topic page.
